Advances in Lung Cancer Basic and Translational Research in 2025-Overview and Perspectives Focusing on NSCLC
Por:
Mascaux, C, Sen, T, Sanchez-Cespedes, M, Ortiz-Cuaran, S, Bossé, Y, Dammeijer, F, Cavic, M, Barr, MP, Arulananda, S, Armisen, R, Berger, AH, Bianchi, F, Carbone, DP, Cerciello, F, Lockwood, WW, Mitsudomi, T, Ohara, S, Politi, K, Qin, SD, Roisman, LC, Samstein, R, Skoulidis, F, Tan, AC, Thomas, A, Zhang, JJ, Wynes, MW, John, T and Tsao, MS
Publicada:
1 oct 2025
Ahead of Print:
1 oct 2025
Resumen:
Basic and translational research in lung cancer is a rapidly evolving field with a transformational impact on early detection, diagnosis, therapeutic development, and personalization of care. Recent advances have greatly increased our understanding of the molecular genomics, proteomics, pathogenesis, and cellular biology of this deadly malignancy. The International Association for the Study of Lung Cancer (IASLC) recently formed a Basic and Translational Science (BaTS) Committee to further enhance the scientific leadership of IASLC in thoracic cancer research. This review by members of the committee highlights the breadth of current research in NSCLC, with a focus on molecular risk factors and processes in tumorigenesis, heterogeneity, phenotypic plasticity, metabolic reprogramming, immunobiology, the immune microenvironment, and microbiome. This review also identifies future research areas that may lead to further improvement in survival outcomes and curative therapies especially for patients with advanced NSCLC. (c) 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Filiaciones:
Mascaux, C:
Univ Hosp Strasbourg, Dept Pulmonol, Strasbourg, France
Strasbourg Univ, Inst Natl St & Rech Med INSERM, Unite Mixte Rech UMR 1260, Regenerat Nanomed NanoRegMed, Strasbourg, France
Sen, T:
Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY USA
:
Josep Carreras Leukaemia Res Inst IJC, Canc Genet Grp, Barcelona, Barcelona, Spain
Ortiz-Cuaran, S:
Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Leon Berard, INSERM 1052,CNRS 5286,Canc Res Ctr Lyon, Lyon, France
Bossé, Y:
Quebec Univ Laval, Inst Univ Cardiol & Pneumol, Quebec City, PQ, Canada
Univ Laval, Dept Mol Med, Quebec City, PQ, Canada
Dammeijer, F:
Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands
Cavic, M:
Inst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade, Serbia
Barr, MP:
Trinity Coll Dublin, Trinity Translat Med Inst, Sch Med, Thorac Oncol Res Grp, Dublin, Ireland
St James Hosp, Trinity St Jamess Canc Inst, Dublin, Ireland
Arulananda, S:
Monash Hlth, Dept Med Oncol, Clayton, Australia
Armisen, R:
Alemana Univ Desarrollo, Fac Med Clin, Ctr Genet & Genom, Santiago, Chile
Berger, AH:
Fred Hutchinson Canc Ctr, Human Biol Div, Seattle, WA USA
Bianchi, F:
Fdn Ist Ricovero & Cura Carattere Sci IRCCS Casa S, Unit Canc Biomarkers, San Giovanni Rotondo, Italy
Carbone, DP:
Ohio State Univ, Dept Med Oncol, Comprehens Canc Ctr, Columbus, OH USA
Pelotonia Inst Immuno Oncol, Columbus, OH USA
Cerciello, F:
Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland
Lockwood, WW:
British Columbia Canc Res Inst, Dept Integrat Oncol, Vancouver, BC, Canada
Mitsudomi, T:
Izumi City Gen Hosp, Izumi, Japan
Kindai Univ, Dept Surg, Div Thorac Surg, Higashiosaka, Osaka, Japan
Ohara, S:
Kindai Univ, Dept Surg, Div Thorac Surg, Higashiosaka, Osaka, Japan
Politi, K:
Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
Qin, SD:
Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Surg, Xian, Shaanxi, Peoples R China
Roisman, LC:
Samson Assuta Hosp, Canc Res Inst, Ashdod, Israel
Ben Gurion Univ Negev, Fac Hlth Sci Microbiol & Immunol, Beer Sheva, Israel
Samstein, R:
Icahn Sch Med Mt Sinai, Dept Radiat Oncol, Dept Immunol & Immunotherapy, New York, NY USA
Skoulidis, F:
Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA
Tan, AC:
Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
Thomas, A:
NCI, Ctr Canc Res, Dev Therapeut Branch, Bethesda, MD USA
Zhang, JJ:
Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA
Wynes, MW:
Int Assoc Study Lung Canc, Denver, CO USA
John, T:
Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia
Tsao, MS:
Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
Univ Toronto, Dept Lab Med, Dept Med Biophys, Toronto, ON, Canada
Green Submitted
|